232 related articles for article (PubMed ID: 31905248)
1. SIRPB1 promotes prostate cancer cell proliferation via Akt activation.
Song Q; Qin S; Pascal LE; Zou C; Wang W; Tong H; Zhang J; Catalona WJ; Dhir R; Morrell M; Balasubramani GK; Lu Y; Wang Z
Prostate; 2020 Mar; 80(4):352-364. PubMed ID: 31905248
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of lncRNA MIR4435‑2HG and ST8SIA1 expression inhibits the proliferation, invasion and migration of prostate cancer cells
Xing P; Wang Y; Zhang L; Ma C; Lu J
Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33846784
[TBL] [Abstract][Full Text] [Related]
3. S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer.
Zhu W; Xue Y; Liang C; Zhang R; Zhang Z; Li H; Su D; Liang X; Zhang Y; Huang Q; Liu M; Li L; Li D; Zhao AZ; Liu Y
Tumour Biol; 2016 Sep; 37(9):12241-12250. PubMed ID: 27240591
[TBL] [Abstract][Full Text] [Related]
4. Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression.
Dozmorov MG; Azzarello JT; Wren JD; Fung KM; Yang Q; Davis JS; Hurst RE; Culkin DJ; Penning TM; Lin HK
BMC Cancer; 2010 Dec; 10():672. PubMed ID: 21134280
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
Jin Y; Cui Z; Li X; Jin X; Peng J
Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of Phospholipase Cε (PLCε) Inhibits Cell Proliferation via Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN)/AKT Signaling Pathway in Human Prostate Cancer.
Wang X; Fan Y; Du Z; Fan J; Hao Y; Wang J; Wu X; Luo C
Med Sci Monit; 2018 Jan; 24():254-263. PubMed ID: 29330357
[TBL] [Abstract][Full Text] [Related]
7. Nimotuzumab inhibits epithelial-mesenchymal transition in prostate cancer by targeting the Akt/YB-1/AR axis.
Hu S; Duan YX; Zhou Q; Wang Y; Lu Q
IUBMB Life; 2019 Jul; 71(7):928-941. PubMed ID: 30907986
[TBL] [Abstract][Full Text] [Related]
8. [P2Y purinergic receptor activated PI-3K/Akt signaling pathway in regulation of growth and invasion of prostatic cancer].
Wang YX; Shi YH; Gong LH; Li Y; Heng WJ; You JF; Zhong HH; Fang WG
Zhonghua Bing Li Xue Za Zhi; 2007 Oct; 36(10):681-6. PubMed ID: 18194602
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.
Tung MC; Hsieh SC; Yang SF; Cheng CW; Tsai RT; Wang SC; Huang MH; Hsieh YH
Prostate; 2013 Sep; 73(12):1281-90. PubMed ID: 23775308
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
11. Chemokine CXCL3 mediates prostate cancer cells proliferation, migration and gene expression changes in an autocrine/paracrine fashion.
Xin H; Cao Y; Shao ML; Zhang W; Zhang CB; Wang JT; Liang LC; Shao WW; Qi YL; Li Y; Zhang ZY; Yang Z; Sun YH; Zhang PX; Jia LL; Wang WQ
Int Urol Nephrol; 2018 May; 50(5):861-868. PubMed ID: 29524043
[TBL] [Abstract][Full Text] [Related]
12. GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway.
Liang F; Yue J; Wang J; Zhang L; Fan R; Zhang H; Zhang Q
Med Oncol; 2015 Mar; 32(3):49. PubMed ID: 25636507
[TBL] [Abstract][Full Text] [Related]
13. Rho-Associated Protein Kinase (ROCK) Promotes Proliferation and Migration of PC-3 and DU145 Prostate Cancer Cells by Targeting LIM Kinase 1 (LIMK1) and Matrix Metalloproteinase-2 (MMP-2).
Gong H; Zhou L; Khelfat L; Qiu G; Wang Y; Mao K; Chen W
Med Sci Monit; 2019 Apr; 25():3090-3099. PubMed ID: 31026254
[TBL] [Abstract][Full Text] [Related]
14. TRAIP suppressed apoptosis and cell cycle to promote prostate cancer proliferation via TRAF2-PI3K-AKT pathway activation.
Gu Y; Liang C
Int Urol Nephrol; 2024 May; 56(5):1639-1648. PubMed ID: 38100027
[TBL] [Abstract][Full Text] [Related]
15. Activation of AKT negatively regulates the pro-apoptotic function of death-associated protein kinase 3 (DAPK3) in prostate cancer.
Das TP; Suman S; Papu John AM; Pal D; Edwards A; Alatassi H; Ankem MK; Damodaran C
Cancer Lett; 2016 Jul; 377(2):134-9. PubMed ID: 27126362
[TBL] [Abstract][Full Text] [Related]
16. Cholestane-3β, 5α, 6β-triol suppresses proliferation, migration, and invasion of human prostate cancer cells.
Lin CY; Huo C; Kuo LK; Hiipakka RA; Jones RB; Lin HP; Hung Y; Su LC; Tseng JC; Kuo YY; Wang YL; Fukui Y; Kao YH; Kokontis JM; Yeh CC; Chen L; Yang SD; Fu HH; Chen YW; Tsai KK; Chang JY; Chuu CP
PLoS One; 2013; 8(6):e65734. PubMed ID: 23785446
[TBL] [Abstract][Full Text] [Related]
17. Lemur Tyrosine Kinase-3 Suppresses Growth of Prostate Cancer Via the AKT and MAPK Signaling Pathways.
Sun P; Sun X; Zhao W; Ren M; Zhang C; Wang Z; Xu W
Cell Physiol Biochem; 2017; 42(6):2582-2592. PubMed ID: 28848113
[TBL] [Abstract][Full Text] [Related]
18. THBS4 silencing regulates the cancer stem cell-like properties in prostate cancer via blocking the PI3K/Akt pathway.
Hou Y; Li H; Huo W
Prostate; 2020 Jul; 80(10):753-763. PubMed ID: 32421868
[TBL] [Abstract][Full Text] [Related]
19. KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cells.
Shen P; Sun J; Xu G; Zhang L; Yang Z; Xia S; Wang Y; Liu Y; Shi G
Prostate; 2014 Jun; 74(9):946-58. PubMed ID: 24737412
[TBL] [Abstract][Full Text] [Related]
20. GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling.
Yan G; Ru Y; Wu K; Yan F; Wang Q; Wang J; Pan T; Zhang M; Han H; Li X; Zou L
Prostate; 2018 Feb; 78(3):166-177. PubMed ID: 29181846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]